Inovio is a Pennsylvania-based biotechnology company that researches, develops, and commercializes synthetic vaccines and immune therapies for the treatment of cancer.
Read moreAnnual Revenue
$6.5M
Inovio's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 86.3M. Over the last four quarters, Inovio's revenue has decreased by 94.8%. Specifically, in Q3 2021's revenue was $ < 1M; in Q2 2021, it was $ < 1M; in Q1 2021, it was $ < 1M; in Q4 2020, Inovio's revenue was $5.6M.
660 West Germantown Pike Suite 110
Plymouth Meeting, Pennsylvania19462
1-267-440-4200
Driving Directions »